SCHEMBL379015

SCHEMBL379015

Oc1ccc(-c2cccc(OCc3ccccc3)c2)cc1/C=C/CCOCc1ccccc1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ERN1 O75460 1/20 0.48
MRGPRX4 Q96LA9 2/20 0.44
MCL1 Q07820 1/20 0.43
FFAR4 Q5NUL3 1/20 0.42
F9 P00740 1/20 0.41
F10 P00742 1/20 0.41
HDAC4 P56524 1/20 0.41
KDM4E B2RXH2 2/20 0.41
NR4A2 P43354 2/20 0.41
ALDH1A1 P00352 1/20 0.41
PKM P14618 1/20 0.41
MAOA P21397 2/20 0.41
MAOB P27338 2/20 0.41
LCK P06239 1/20 0.41
PELI1 Q96FA3 1/20 0.41
CYP4F2 P78329 1/20 0.40
CYP4A11 Q02928 1/20 0.40
CYSLTR2 Q9NS75 1/20 0.40
CYSLTR1 Q9Y271 1/20 0.40
HSP90AA1 P07900 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL379016 1.00 ERN1 (0.48) ERN1MRGPRX4MCL1FFAR4F9
SCHEMBL378950 0.77 MAOB (0.49) ERN1MAOBHSP90AA1MAPTMAPK1
SCHEMBL379017 0.77 MAOB (0.49) ERN1MAOBHSP90AA1MAPTMAPK1
SCHEMBL12635750 0.76 PTGER1 (0.46) ERN1MRGPRX4FFAR4MAPTMAPK1
SCHEMBL7346174 0.73 MRGPRX4 (0.64) ERN1MRGPRX4MCL1F9F10
SCHEMBL379281 0.73 MAOB (0.67) MRGPRX4FFAR4NR4A2MAOAMAOB
SCHEMBL8450255 0.72 HPGD (0.49) ERN1F10KDM4EALDH1A1MAPT
SCHEMBL2137838 0.72 MRGPRX4 (0.69) MRGPRX4HDAC4NR4A2MAOAMAOB
SCHEMBL16346074 0.70 GSTP1 (0.66) MRGPRX4MCL1FFAR4HDAC4NR4A2
SCHEMBL7046152 0.69 MAOB (0.56) MCL1MAOAMAOBLCK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8313669-B2 Liquid-crystal display MERCK Patent Gesellschaft mit beschränkter Haftung (DE) 2012-11-20 US disclosed
EP-2181174-B1 LIQUID CRYSTAL DISPLAY MERCK PATENT GMBH (DE) 2012-01-25 EP disclosed
US-20110101269-A1 LIQUID-CRYSTAL DISPLAY MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) 2011-05-05 US disclosed
EP-2181174-A1 LIQUID CRYSTAL DISPLAY Merck Patent GmbH (DE) 2010-05-05 EP disclosed
WO-2009030322-A1 LIQUID CRYSTAL DISPLAY MERCK PATENT GMBH (DE) 2009-03-12 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110101269-A1 LIQUID-CRYSTAL DISPLAY KLK3, LPXN, PSAP ERN1 4101/4885MRGPRX4 3808/4885MCL1 793/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.